진단 조사 리뷰(2025년)

The global market for human microbiome-based drugs and diagnostics was valued at $315.2 million in 2024 and is expected to reach $1.2 billion by the end of 2030, at a CAGR of 25.6% from 2025 to 2030.

The global market for molecular diagnostics was valued at $20.3 billion in 2024 and is expected to reach $42.6 billion by the end of 2030, at a CAGR of 13.1% from 2025 to 2030.

The global market for noninvasive cancer diagnostics was valued at $112.8 billion in 2024 and is projected to reach $165.2 billion by the end of 2030, at a CAGR of 6.6% from 2025 to 2030.

Report Scope

The diagnostics industry has grown despite the challenging economic conditions in recent years. The industry draws much attention and scrutiny from the public and government, and is currently undergoing many changes due to increased focus on regulations. These changes can be seen across many countries. The U.S., the largest diagnostics market, is leading the trend with changes intended to make healthcare more affordable. Opportunities for the diagnostics industry are manifold, with the appearance of new markets located mainly in emerging economies with varying needs.

Increasing healthcare expenditures and the growth of emerging economies have increased the demand for technologically better diagnostic devices, kits, reagents, and other accessories. Additionally, the introduction of more stringent regulations, specifically in the developed markets of the U.S. and Europe, has forced diagnostics manufacturers to launch advanced products that include new materials, a focus on in-depth indications, and the ability to produce additional new data.

Some of the major driving factors in the market are the increasing prevalence of chronic and infectious diseases, technological advances in diagnostics, increasing investments in AI in the diagnostics market, increased applications in non-oncology areas, and growing adoption of personalized medicine.

Furthermore, technically sophisticated diagnostics are needed for clinical research, as the market is highly competitive, and companies must continuously reinvent their product portfolios to enter new markets and place themselves as key participants in the healthcare system. There is a shift toward a value-based healthcare market where price and purchase decisions are based on outcomes. This has further led to increased scrutiny of device technology, and consequently, the degree of competition has risen. Some of the major firms in the diagnostics market include Abbott, Medtronic, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Agilent Technologies Inc., QIAGEN, Danaher Corp., Sysmex, Thermo Fisher Scientific Inc., BD, and others.

The diagnostics industry is a multi-billion-dollar market with an outlook for continued growth in the coming years. Hospital care is growing, and the diagnostics industry is being looked at to provide low-cost technology for home healthcare. Now, the industry seeks healthcare diagnostic devices, kits, and reagents that individuals with unskilled healthcare experience can use. The need for modern technology, equipment, and devices can be leveraged through diagnostic equipment as manufacturers seek to create better-quality healthcare solutions.

The above reasons are compelling enough to analyze and research the diagnostics market, as the market has tremendous growth potential.

It includes highlights from these reports published in 2024:

MDS051B Tissue Diagnostics: Technologies and Global Markets

• HLC300A Global Colorectal Cancer Screening and Diagnostics Market
• MDS046B Oncology Diagnostics: Global Markets
• BIO150E Liquid Biopsy Research Tools, Services, and Diagnostics
• BIO151B Human Microbiome-based Drugs and Diagnostics
• BIO063F Molecular Diagnostics: Technologies and Global Markets
• HLC186D In Vitro Diagnostics: Technologies and Global Markets
• PHM026D Global Markets for Allergy Diagnostics and Treatments
• HLC197B Noninvasive Cancer Diagnostics: Technologies and Global Markets
• HLC029G Global Markets for Diabetes Therapeutics and Diagnostics

After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.

Table of Contents

Chapter 1 Foreword

• Research Review Scope

Chapter 2 Tissue Diagnostics: Technologies and Global Markets (MDS051B)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview and Definitions
• Immunohistochemistry (IHC)
• In Situ Hybridization
• Polymerase Chain Reaction
• Next-Generation Sequencing
• General Culture Testing
• Market Dynamics
• Market Drivers
• Market Opportunities
• Market Restraints
• Market Challenges
• Emerging Technologies and Developments
• Market Breakdown
• Market Breakdown by Product Type
• Market Breakdown by Segment
• Histopathology Market
• Molecular Pathology Market
• Microbiology Testing Market
• Digital Pathology Market
• Market Breakdown by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Rest of the World
• Sustainability in the Market for Tissue Diagnostics: An ESG Perspective
• Introduction to ESG
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC

Chapter 3 Global Colorectal Cancer Screening and Diagnostics Market (HLC300A)

• Market Outlook
• Scope of Report
• Market Insights
• Market Overview
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies
• Global Market for Colorectal Cancer Screening and Diagnostic Testing Services
• Market Analysis by Test Type
• Colonoscopy and Sigmoidoscopy Tests
• Stool DNA Tests
• Blood-Based/Biomarker Tests
• Fecal Occult Blood Tests (FOBT)
• Fecal Immunochemical Tests (FIT)
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the Colorectal Cancer Screening and Diagnostic Testing Service Market
• Introduction
• Sustainability
• Concluding Remarks from BCC

Chapter 4 Oncology Diagnostics: Global Markets (MDS046B)

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Strategic Initiatives
• Conclusion
• Market Overview
• Market Dynamics
• Market Drivers
• Market Opportunities
• Market Restraints
• Market Challenges
• Emerging Technologies
• Global Market Insights
• Market Breakdown by Product Type
• Diagnostics Imaging
• Endoscopy Devices
• Tumor Biomarker Tests
• Biopsy Devices
• Hematoxylin and Eosin
• Immunohistochemistry
• In situ Hybridization
• Polymerase Chain Reaction
• Next-Generation Sequencing
• Others
• Market Breakdown by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa (MEA)
• Sustainability in the Market for Oncology Diagnostics: An ESG Perspective
• Introduction to ESG
• ESG Performance Analysis
• Concluding Remarks from BCC

Chapter 5 Liquid Biopsy Research Tools, Services and Diagnostics (BIO150E)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies
• Market Trends
• Global Market for Liquid Biopsy by Application
• Non-invasive Prenatal Testing (NIPT)
• Cancer
• Organ Transplantation
• Global Market for Liquid Biopsy by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)
• Sustainability in the Liquid Biopsy Market: ESG Perspective
• Introduction to ESG
• ESG Practices in the Liquid Biopsy Industry
• Environmental Performance
• Social Performance
• Governance Performance
• ESG Risk Ratings
• Concluding Remarks from BCC Research

Chapter 6 Human Microbiome-based Drugs and Diagnostics (BIO151B)

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics
• Emerging Technologies
• Analysis by Segment
• Regional Analysis
• Conclusion
• Overview and Market Definition
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies
• Market Analysis by Type
• Microbiome-based Drugs
• Microbiome-based Diagnostics
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa
• Sustainability in the Human Microbiome-based Drugs and Diagnostics Industry: An ESG Perspective
• Introduction to ESG
• ESG Risk Ratings
• Concluding Remarks

Chapter 7 Molecular Diagnostics: Technologies and Global Markets (BIO063F)

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion
• Market Overview
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies
• Market Analysis by Technology
• Key Takeaways
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing (NGS)
• In Situ Hybridization
• Microarrays
• Others
• Market Analysis by Product and Service
• Key Takeaways
• Consumables
• Instruments
• Software and Services
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the Molecular Diagnostics Market: An ESG Perspective
• Introduction to ESG
• ESG Practices in the Molecular Diagnostics Industry
• ESG Risk Ratings
• Conclusion

Chapter 8 In Vitro Diagnostics: Technologies and Global Markets (HLC186D)

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies in the IVD Market
• Market Analysis by Technology
• Immunochemistry
• POC Testing
• Hematology
• Molecular Diagnostics
• Tissue Diagnostics
• Clinical Microbiology
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
• Sustainability in the In Vitro Diagnostics Industry: An ESG Perspective
• Importance of ESG in In Vitro Diagnostics Manufacturing Industry
• ESG Practices in the In Vitro Diagnostics Industry
• Environmental Performance
• Social Performance
• Governance Performance
• Company Role in ESG Development
• ESG Risk Ratings
• BCC Research Viewpoint

Chapter 9 Global Markets for Allergy Diagnostics and Treatments (PHM026D)

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Segmental Analysis
• Regional Analysis
• Conclusion
• Market Overview
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies
• Global Allergy Diagnostics and Treatment Market by Type
• Key Takeaways
• Diagnostics
• Treatments
• Global Allergy Diagnostics and Treatment Market by Drug Type
• Key Takeaways
• Prescription Drugs
• Over-the-Counter Drugs
• Global Allergy Diagnostics and Treatment Market by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Middle East and Africa (MEA)
• South America
• Sustainability in the Allergy Diagnostics and Treatment Market:ESG Perspective
• Introduction to ESG
• Role of ESG in the Allergy Diagnostics and Treatment Market
• ESG Risk Ratings
• Conclusion

Chapter 10 Noninvasive Cancer Diagnostics: Technologies and Global Markets (HLC197B)

• Market Outlook
• Scope of the Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion
• Current Market Overview
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Challenges
• Emerging Technologies
• Market Analysis by Cancer Type
• Key Takeaways
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Cervical Cancer
• Stomach Cancer
• Liver Cancer
• Esophageal Cancer
• Bladder Cancer
• All Other Cancers
• Market Analysis by Technology Type
• Key Takeaways
• Diagnostic Imaging Technologies
• Advanced Noninvasive Approaches
• Conventional Noninvasive Cancer Screening, Diagnostic Assays and Tests
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa
• Sustainability in Global Noninvasive Cancer Diagnostics Market: An ESG Perspective
• Introduction to ESG
• Major Manufacturers: ESG Efforts
• Concluding Remarks from BCC Research

Chapter 11 Global Markets for Diabetes Therapeutics and Diagnostics (HLC029G)

• Market Outlook
• Scope of Report
• Market Summary
• Overview
• Current Market Scenario
• Segmental Analysis
• Technological Advances
• Conclusion
• Market Overview
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Challenges
• Emerging Technologies
• Global Diabetes Therapeutics and Diagnostic Market by Product
• Key Takeaways
• Diabetes Therapeutics
• Diabetes Monitoring Devices and Accessories
• Insulin Delivery Devices
• Global Diabetes Therapeutics and Diagnostic Market by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• South America
• Sustainability in the Diabetes Therapeutics and Diagnostics Market: An ESG Perspective
• Introduction to ESG
• ESG in Diabetes Therapeutics and Diagnostics
• ESG Performance Analysis
• Concluding Remarks from BCC

Chapter 12 Appendix

• Methodology
• Analyst's Credentials